In the News

Chinese people have higher risk of hereditary Lynch syndrome and cancer

Singapore's NPM Programme found Chinese individuals have a higher prevalence of Lynch syndrome, raising cancer risks significantly, making genetic testing a key tool for early intervention.

GSK Joins PRECISE–SG100K PCC as 5th Pharma Partner

GSK’s participation in the PRECISE–SG100K Pharma Pre Competitive Consortium (PCC) reflects growing industry recognition of Singapore’s National Precision Medicine (NPM) and the PRECISE- SG100K project, as a strategic platform for collaboration in advancing national population health and strengthening Singapore’s position as a trusted hub for precision medicine research in Asia.

PRECISE–SG100K advances population scale proteomics with Thermo Fisher Scientific and Seer

PRECISE has partnered with Thermo Fisher and Seer to add advanced protein analysis to one of the largest and most diverse Asian population health cohorts – PRECISE-SG100K.

PRECISE Expands Microbiome–Mental Health Research Internationally with UW–Madison

GLOW programme expands internationally through a new partnership with UW-Madison, adding 1,500 US participants to study how gut microbiome links to mental health and explore how mindfulness practices influence the gut-brain axis.

GA4GH 14th Plenary will take place in Singapore

The Global Alliance for Genomics and Health (GA4GH) will hold its 14th Plenary meeting from 28 September to 2 October 2026 in Singapore.

Healthcare That’s Fit For The Future

Singapore’s National Precision Medicine Programme has won the 2026 Global Future Fit Seal Award for setting the standard in data-driven healthcare.

PRECISE Announces Landmark Partnership

Precision Health Research, Singapore (PRECISE) Announces Landmark Partnership with Alnylam, Bayer, Boehringer Ingelheim and Novo Nordisk to Advance Asian Precision Medicine Research

Singapore Launches Phase III of National Precision Medicine (NPM) Programme

Singapore Launches Phase III of National Precision Medicine (NPM) Programme Forming Strategic Partnerships for Better Health

Singapore to Embark on Study Exploring Links Between Asian Gut Microbiomes and Mental Health

A new research initiative, GLOW (Gut Linked Outcomes in Wellbeing) will be launched in Singapore to investigate how the human gut microbiome—often described as the body’s “second genome”—influences mental health.

Media Coverage: We Foresee More Cross Border Collaborations Leveraging Advanced Technologies